Nicholas Sanderson started his founder journey building software for small businesses in Australia. What began as a series of bespoke websites for local practices quickly revealed a deeper, more systemic problem – one that clinicians across Allied Health disciplines knew all too well.

Running a practice had become increasingly complex: scheduling, documentation, billing, compliance, and patient communication were fragmented across outdated tools and manual workflows. Clinicians were spending less time delivering care and more time dealing with the administrative headaches of running a business. The software meant to help them had not kept pace with how practices, patient expectations, and the healthcare system around them were evolving.

Nick’s response was to found splose – purpose-built to solve the exact problems he’d seen clinicians struggle to manage.

Today, splose has grown into an AI-enabled practice management platform serving more than 20,000 clinicians across Australia, the UK, and New Zealand – including physical therapists, occupational therapists, speech pathologists, mental health professionals, and other clinical disciplines collectively known as “Allied Health.” After spending time with Nick and the splose team over the past year, we’re excited to announce Spectrum Equity’s investment in the company.

A Market Shaped by Structural Tailwinds

Allied Health is one of the fastest-growing segments of healthcare in Australia. An aging population, expanded government funding programs such as NDIS / Medicare, and a sustained shift toward community-based, preventative care are driving durable growth across clinical categories. At the same time, practices are scaling in size and complexity – placing new demands on the systems that support them.

Yet much of the software ecosystem serving this market was built more than a decade ago. Many incumbent platforms struggle with modern workflows, complex payer rules, or the realities of multi-clinician practices – and most have been slow to integrate AI in ways that meaningfully reduce the administrative burden on clinicians. As a result, practices often stitch together multiple point solutions, introducing inefficiency, errors, and frustration.

splose was designed from the ground up to address these challenges. The platform unifies intake, scheduling, patient communication, clinical documentation, invoicing, and reporting into a single system of record – and system of action – purpose-built for Allied Health. AI has been embedded into the splose platform – from real-time session transcription and automated clinical note generation to intelligent scheduling and reporting – so that practitioners can spend less time on documentation and more time on patient care. Payer and funding logic is woven directly into daily workflows, enabling practices to bill accurately and confidently without relying on spreadsheets or manual reconciliation. Across our diligence, we repeatedly heard the same refrain from clinicians: splose “just works” in a way legacy systems do not.

Product-Led Adoption, Proven at Scale

At Spectrum, we are often drawn to businesses where customer enthusiasm precedes formal go-to-market scale – and splose fits that pattern well. The company has established itself as an emerging category leader in Australia, with strong inbound momentum and a customer acquisition engine that’s part user referral-driven. Many clinicians discover splose through peers, onboard via a self-serve motion, and expand usage organically as their practices grow.

Beyond its community-led virality, splose is a deeply entrenched, daily-use product, supporting millions of appointments each month. Customers consistently cite meaningful time savings for both clinicians and administrative staff, improved billing accuracy, and reduced operational complexity – clear signals of a system that has become mission-critical to practice operations across sizes, from solo practitioners to multi-site clinics.

Because splose already sits at the center of clinical and administrative workflows, it has a natural right to expand. AI-powered features are already seeing meaningful adoption, and the platform’s control point over invoicing – facilitating more than A$1 billion in annual payments volume – creates a compelling foundation for integrated payments over time.

A Familiar Pattern and Industry

splose reflects many of the patterns we actively seek out at Spectrum:

• Community-driven, bottom-up adoption rooted in genuine customer advocacy
• Mission-critical, vertical software platforms that become systems of record and daily systems of action
• Founder-led businesses entering a critical next phase of growth and professionalization

This investment represents the continuation of Spectrum’s franchise in healthcare technology and provider-oriented software. Spectrum previously invested in Net Health (clinical software for outpatient specialty care markets), Passport Health (provider-focused revenue cycle management software for eligibility and benefits verification), and RxVantage (two-sided network for providers to access and engage with life sciences professionals).

This also represents a continuation of our time spent in the Australian market. Spectrum has been eager to find and partner with exceptional software businesses in Australia for quite some time, following our 2011 investment in iSelect, which we exited via IPO in 2013. We believe the Australian software ecosystem continues to produce high-quality, globally relevant companies, and we’re excited to continue supporting that ecosystem through this partnership.

Partnering for the Road Ahead

Under Nicholas Sanderson’s leadership, we believe splose is poised to deliver even greater value to Allied Health clinicians and the patients they serve. In recent years, the company has invested meaningfully in strengthening its leadership team – welcoming Kon Knafelman as CFO, Anna Kelk as Chief Product Officer, Isaac Mann as CTO, and Liam Smee as Chief Growth Officer – while continuing to benefit from the experience and partnership of EVP, alongside new investors including Athletic Ventures.

Together, this team is focused on scaling product innovation, deepening engagement across the Allied Health community, and building the operational foundation required for the company’s next chapter of growth. We’re thrilled to partner with Nick and the entire splose team as they continue to help clinicians spend less time on administration and more time delivering high-quality care – by building the operating system for modern Allied Health practices.

Portfolio company referenced is for informational purposes only and does not constitute an offer, solicitation or recommendation to sell or purchase, any securities, investment products or investment advisory services. For a list of Spectrum Equity’s portfolio companies, please visit https://spctrm.pe/list-of-investments, which is updated periodically and reflects investments that have been publicly announced. No assumption should be made that any portfolio company shown was or will be profitable. The forward-looking statements and views expressed herein are those of Spectrum Equity as of the date indicated and are subject to change without notice..